These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 1541067

  • 1. Anti-platelet therapy in diabetic and non-diabetic progressive renal failure.
    Gordge MP, Rylance PB, Neild GH.
    Clin Nephrol; 1992 Jan; 37(1):53-5. PubMed ID: 1541067
    [No Abstract] [Full Text] [Related]

  • 2. Administration of aspirin-dipyridamole reduces proteinuria in diabetic nephropathy.
    Hopper AH, Tindall H, Davies JA.
    Nephrol Dial Transplant; 1989 Jan; 4(2):140-3. PubMed ID: 2496357
    [Abstract] [Full Text] [Related]

  • 3. The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modifications.
    Viecelli AK, Pascoe E, Polkinghorne KR, Hawley C, Paul-Brent PA, Badve SV, Cass A, Heritier S, Kerr PG, Mori TA, Robertson A, Seong HL, Irish AB, FAVOURED study team.
    BMC Nephrol; 2015 Jun 27; 16():89. PubMed ID: 26116581
    [Abstract] [Full Text] [Related]

  • 4. Dietary protein restriction versus fish oil supplementation in the chronic remnant nephron model.
    Clark WF, Parbtani A, Philbrick DJ, Spanner E, Huff MW, Holub BJ.
    Clin Nephrol; 1993 Jun 27; 39(6):295-304. PubMed ID: 8334756
    [Abstract] [Full Text] [Related]

  • 5. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H, Kanno Y, Nakamoto H, Okada H, Sugahara S.
    Clin Exp Hypertens; 2005 Jun 27; 27(2-3):129-38. PubMed ID: 15835375
    [Abstract] [Full Text] [Related]

  • 6. A comparative randomized and placebo-controlled short-term trial of aspirin and dipyridamole for overt type-2 diabetic nephropathy.
    Khajehdehi P, Roozbeh J, Mostafavi H.
    Scand J Urol Nephrol; 2002 Jun 27; 36(2):145-8. PubMed ID: 12028688
    [Abstract] [Full Text] [Related]

  • 7. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F.
    Nefrologia; 2008 Jun 27; 28 Suppl 3():39-48. PubMed ID: 19018737
    [Abstract] [Full Text] [Related]

  • 8. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L, Kocks MJ, Laverman GD, Navis G.
    Minerva Med; 2004 Oct 27; 95(5):395-409. PubMed ID: 15467515
    [Abstract] [Full Text] [Related]

  • 9. Effect of fish oil on oxidative stress, lipid profile and renal function in IgA nephropathy.
    Parinyasiri U, Ong-Ajyooth L, Parichatikanond P, Ong-Ajyooth S, Liammongkolkul S, Kanyog S.
    J Med Assoc Thai; 2004 Feb 27; 87(2):143-9. PubMed ID: 15061297
    [Abstract] [Full Text] [Related]

  • 10. [Effect of treating glomerulonephritis with omega 3 fatty acids for selected parameters of hemostasis, blood platelet function and lipid metabolism].
    Małyszko JS, Małyszko J, Pawlak K, Myśliwiec M.
    Przegl Lek; 1996 Feb 27; 53(8):600-3. PubMed ID: 8999460
    [Abstract] [Full Text] [Related]

  • 11. Results of a 1-year randomized controlled trial with omega-3 fatty acid fish oil in renal transplantation under triple immunosuppressive therapy.
    Maachi K, Berthoux P, Burgard G, Alamartine E, Berthoux F.
    Transplant Proc; 1995 Feb 27; 27(1):846-9. PubMed ID: 7879202
    [No Abstract] [Full Text] [Related]

  • 12. Relationship of omega-3 fatty acid supplementation to plasma lipid peroxidation in predialysis patients with hypertriglyceridaemia.
    Richard MJ, Sirajeddine MK, Cordonnier D, Tricot F, Foulon T, Mouneimne A, Maurizi J.
    Eur J Med; 1993 Jan 27; 2(1):15-8. PubMed ID: 8257999
    [Abstract] [Full Text] [Related]

  • 13. Preventive cardiology: what is the value of antiplatelet agents and fish oils?
    Lavie CJ, Squires RW, Gau GT.
    South Med J; 1988 Sep 27; 81(9):1145-50. PubMed ID: 3047882
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Platelet-inhibitor treatment of diabetic nephropathy: a 10-year prospective study.
    Donadio JV, Ilstrup DM, Holley KE, Romero JC.
    Mayo Clin Proc; 1988 Jan 27; 63(1):3-15. PubMed ID: 3336239
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Marine oil capsule therapy for the treatment of hyperlipidemia.
    Davidson MH, Burns JH, Subbaiah PV, Conn ME, Drennan KB.
    Arch Intern Med; 1991 Sep 27; 151(9):1732-40. PubMed ID: 1888238
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.